81 related articles for article (PubMed ID: 9051307)
1. Bidirectional modulatory effect of orphanin FQ on morphine-induced analgesia: antagonism in brain and potentiation in spinal cord of the rat.
Tian JH; Xu W; Fang Y; Mogil JS; Grisel JE; Grandy DK; Han JS
Br J Pharmacol; 1997 Feb; 120(4):676-80. PubMed ID: 9051307
[TBL] [Abstract][Full Text] [Related]
2. BPR1M97, a dual mu opioid receptor/nociceptin-orphanin FQ peptide receptor agonist, produces potent antinociceptive effects with safer properties than morphine.
Chao PK; Chang HF; Chang WT; Yeh TK; Ou LC; Chuang JY; Tsu-An Hsu J; Tao PL; Loh HH; Shih C; Ueng SH; Yeh SH
Neuropharmacology; 2020 Apr; 166():107678. PubMed ID: 31278929
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, Biological Activity and Molecular Docking of Chimeric Peptides Targeting Opioid and NOP Receptors.
Wtorek K; Ghidini A; Gentilucci L; Adamska-Bartłomiejczyk A; Piekielna-Ciesielska J; Ruzza C; Sturaro C; Calò G; Pieretti S; Kluczyk A; McDonald J; Lambert DG; Janecka A
Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293553
[TBL] [Abstract][Full Text] [Related]
4. The NOP Receptor System in Neurological and Psychiatric Disorders: Discrepancies, Peculiarities and Clinical Progress in Developing Targeted Therapies.
Toll L; Cippitelli A; Ozawa A
CNS Drugs; 2021 Jun; 35(6):591-607. PubMed ID: 34057709
[TBL] [Abstract][Full Text] [Related]
5. Oxycodone in the Opioid Epidemic: High 'Liking', 'Wanting', and Abuse Liability.
Kibaly C; Alderete JA; Liu SH; Nasef HS; Law PY; Evans CJ; Cahill CM
Cell Mol Neurobiol; 2021 Jul; 41(5):899-926. PubMed ID: 33245509
[TBL] [Abstract][Full Text] [Related]
6. Crosstalk between Opioid and Anti-Opioid Systems: An Overview and Its Possible Therapeutic Significance.
Gibula-Tarlowska E; Kotlinska JH
Biomolecules; 2020 Sep; 10(10):. PubMed ID: 32998249
[TBL] [Abstract][Full Text] [Related]
7. Interactive Mechanisms of Supraspinal Sites of Opioid Analgesic Action: A Festschrift to Dr. Gavril W. Pasternak.
Rossi GC; Bodnar RJ
Cell Mol Neurobiol; 2021 Jul; 41(5):863-897. PubMed ID: 32970288
[TBL] [Abstract][Full Text] [Related]
8. Role of mu-opioid agonist efficacy on antinociceptive interactions between mu agonists and the nociceptin opioid peptide agonist Ro 64-6198 in rhesus monkeys.
Cornelissen JC; Steele FF; Tenney RD; Obeng S; Rice KC; Zhang Y; Banks ML
Eur J Pharmacol; 2019 Feb; 844():175-182. PubMed ID: 30552903
[TBL] [Abstract][Full Text] [Related]
9. Nociceptin/orphanin FQ receptor ligands and translational challenges: focus on cebranopadol as an innovative analgesic.
Calo G; Lambert DG
Br J Anaesth; 2018 Nov; 121(5):1105-1114. PubMed ID: 30336855
[TBL] [Abstract][Full Text] [Related]
10. ORL
Wu Q; Liu L
J Mol Neurosci; 2018 Sep; 66(1):10-16. PubMed ID: 30074175
[TBL] [Abstract][Full Text] [Related]
11. Analysis of the distribution of spinal NOP receptors in a chronic pain model using NOP-eGFP knock-in mice.
Ozawa A; Brunori G; Cippitelli A; Toll N; Schoch J; Kieffer BL; Toll L
Br J Pharmacol; 2018 Jul; 175(13):2662-2675. PubMed ID: 29582417
[TBL] [Abstract][Full Text] [Related]
12. Involvement of the N/OFQ-NOP system in rat morphine antinociceptive tolerance: Are astrocytes the crossroad?
Micheli L; Lucarini E; Corti F; Ciccocioppo R; Calò G; Rizzi A; Ghelardini C; Di Cesare Mannelli L
Eur J Pharmacol; 2018 Mar; 823():79-86. PubMed ID: 29378191
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of cebranopadol, a dually acting nociceptin/orphanin FQ and opioid receptor agonist in mouse models of acute, tonic, and chemotherapy-induced neuropathic pain.
Sałat K; Furgała A; Sałat R
Inflammopharmacology; 2018 Apr; 26(2):361-374. PubMed ID: 29071457
[TBL] [Abstract][Full Text] [Related]
14. Bifunctional peptide-based opioid agonist/nociceptin antagonist ligand for dual treatment of nociceptive and neuropathic pain.
Lagard C; Chevillard L; Guillemyn K; Risède P; Laplanche JL; Spetea M; Ballet S; Mégarbane B
Pain; 2017 Mar; 158(3):505-515. PubMed ID: 28135212
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological characterization of cebranopadol a novel analgesic acting as mixed nociceptin/orphanin FQ and opioid receptor agonist.
Rizzi A; Cerlesi MC; Ruzza C; Malfacini D; Ferrari F; Bianco S; Costa T; Guerrini R; Trapella C; Calo' G
Pharmacol Res Perspect; 2016 Aug; 4(4):e00247. PubMed ID: 28116100
[TBL] [Abstract][Full Text] [Related]
16. Characterisation of the Novel Mixed Mu-NOP Peptide Ligand Dermorphin-N/OFQ (DeNo).
Bird MF; Cerlesi MC; Brown M; Malfacini D; Vezzi V; Molinari P; Micheli L; Di Cesare Mannelli L; Ghelardini C; Guerrini R; Calò G; Lambert DG
PLoS One; 2016; 11(6):e0156897. PubMed ID: 27272042
[TBL] [Abstract][Full Text] [Related]
17. Bifunctional Peptide-Based Opioid Agonist-Nociceptin Antagonist Ligands for Dual Treatment of Acute and Neuropathic Pain.
Guillemyn K; Starnowska J; Lagard C; Dyniewicz J; Rojewska E; Mika J; Chung NN; Utard V; Kosson P; Lipkowski AW; Chevillard L; Arranz-Gibert P; Teixidó M; Megarbane B; Tourwé D; Simonin F; Przewlocka B; Schiller PW; Ballet S
J Med Chem; 2016 Apr; 59(8):3777-92. PubMed ID: 27035422
[TBL] [Abstract][Full Text] [Related]
18. Central N/OFQ-NOP Receptor System in Pain Modulation.
Kiguchi N; Ding H; Ko MC
Adv Pharmacol; 2016; 75():217-43. PubMed ID: 26920014
[TBL] [Abstract][Full Text] [Related]
19. Knock-In Mice with NOP-eGFP Receptors Identify Receptor Cellular and Regional Localization.
Ozawa A; Brunori G; Mercatelli D; Wu J; Cippitelli A; Zou B; Xie XS; Williams M; Zaveri NT; Low S; Scherrer G; Kieffer BL; Toll L
J Neurosci; 2015 Aug; 35(33):11682-93. PubMed ID: 26290245
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
